Martin de Bock
YOU?
Author Swipe
View article: The usability and feasibility of a self‐compassion chatbot (<scp>COMPASS</scp>) for youth living with type 1 diabetes
The usability and feasibility of a self‐compassion chatbot (<span>COMPASS</span>) for youth living with type 1 diabetes Open
Aim Although it is well established that youth with type 1 Diabetes (T1D) experience high rates of distress, current clinical care is often under‐resourced and unable to provide sufficient or timely psychological support. The current study…
View article: First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 Diabetes
First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 Diabetes Open
Background: This feasibility study assessed a novel self-adapting closed-loop system which does not require carbohydrate announcement, in adults with type 1 and type 2 diabetes. Methods: Single-arm study, comprising a 14-day run-in using p…
View article: Lifting Wellbeing in Youth with Diabetes: Exploring User Experiences with the LIFT App (Preprint)
Lifting Wellbeing in Youth with Diabetes: Exploring User Experiences with the LIFT App (Preprint) Open
BACKGROUND Individuals living with type 1 diabetes (T1D) are at an increased risk of experiencing psychological distress; however, there remains a scarcity of scalable and widely accessible support services, particularly for adolescents a…
View article: Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high <scp>HbA1c</scp> : Sleep outcomes from the <scp>CO</scp> ‐ <scp>PILOT</scp> randomised controlled trial
Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high <span>HbA1c</span> : Sleep outcomes from the <span>CO</span> ‐ <span>PILOT</span> randomised controlled trial Open
Aims To assess how automated insulin delivery (AID) impacts sleep in young people with type 1 diabetes and suboptimal glycaemia (HbA1c ≥ 69 mmol/mol). Methods We conducted a randomised controlled trial comparing AID to usual care in 80 par…
View article: Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT app
Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT app Open
LIFT was deemed engaging, safe and feasible with promising preliminary changes in psychological outcomes.
View article: Impact of Simplera Sync™ sensors and Extended™ Wear Infusion Sets on glycaemia and system performance of the <scp>MiniMed</scp>™ <scp>780G</scp> system in children and young adults with previously high <scp>HbA1c</scp>
Impact of Simplera Sync™ sensors and Extended™ Wear Infusion Sets on glycaemia and system performance of the <span>MiniMed</span>™ <span>780G</span> system in children and young adults with previously high <span>HbA1c</span> Open
Aims The MiniMed™ 780G improves glycaemia and reduces burden in type 1 diabetes. We investigated how new all‐in‐one “Simplera Sync™” sensors and 7‐day Extended™ Wear Infusion Sets (EIS) affect glycaemia and system performance in young peop…
View article: Developing a multicomponent intervention to increase glucose time in range in adolescents and young adults with type 1 diabetes: An optimisation trial to screen continuous glucose monitoring, sleep extension, healthier snacking and values-guided self-management intervention components
Developing a multicomponent intervention to increase glucose time in range in adolescents and young adults with type 1 diabetes: An optimisation trial to screen continuous glucose monitoring, sleep extension, healthier snacking and values-guided self-management intervention components Open
The values-guided self-management was the only 'active' component. Conclusions about the less impactful intervention components are limited due to disruptions in research activities from the COVID-19 pandemic. Future work will address othe…
View article: Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery
Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery Open
Objective: Rapid improvements in glucose control may lead to early worsening of diabetic retinopathy (EWDR). There is a need to demonstrate safety in people commencing automated insulin delivery (AID) due to the known efficacy in rapid gly…
View article: Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated <scp>HbA1c</scp> using the <scp>MiniMed 780G</scp> system
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated <span>HbA1c</span> using the <span>MiniMed 780G</span> system Open
Aims This study aimed to identify key factors with the greatest influence on glycaemic outcomes in young individuals with type 1 diabetes (T1D) and very elevated glycaemia after 3 months of automated insulin delivery (AID). Materials and M…
View article: ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets
ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets Open
Summary of what is New or Different 1. This chapter recommends a target HbA1c of ≤6.5% (48mmol/mol) for those who have access to advanced diabetes technologies like continuous glucose monitoring (CGM) and automated insulin delivery (AID). …
View article: Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global Perspective
Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global Perspective Open
Globally, nearly 9 million people are living with type 1 diabetes (T1D). Although the incidence of T1D is not affected by socioeconomic status, the development of complications and limited access to modern therapy is overrepresented in vul…
View article: Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia
Parental perspectives following the implementation of advanced hybrid closed‐loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia Open
Aims To identify from a parental perspective facilitators and barriers of effective implementation of advanced hybrid closed‐loop (AHCL) therapy in children and adolescents with type 1 diabetes (T1D) with elevated glycaemia. Methods Semi‐s…
View article: Single-arm, first-in-human feasibility study results for an ultra-low-cost insulin pump
Single-arm, first-in-human feasibility study results for an ultra-low-cost insulin pump Open
Background Use of Continuous Subcutaneous Insulin Infusion (CSII) has been shown to improve glycemic outcomes in Type 1 Diabetes (T1D), but high costs limit accessibility. To address this issue, an inter-operable, open-source Ultra-Low-Cos…
View article: Real time continuous glucose monitoring in high‐risk people with insulin‐requiring type 2 diabetes: A randomised controlled trial
Real time continuous glucose monitoring in high‐risk people with insulin‐requiring type 2 diabetes: A randomised controlled trial Open
Aims To investigate the impact of real‐time continuous glucose monitoring (rtCGM) on glycaemia in a predominantly indigenous (Māori) population of adults with insulin‐requiring type 2 diabetes (T2D) in New Zealand. Methods Twelve‐week, mul…
View article: Children and adolescents with type 1 diabetes in <scp>Aotearoa New Zealand</scp>: An online survey of workforce and outcomes 2021
Children and adolescents with type 1 diabetes in <span>Aotearoa New Zealand</span>: An online survey of workforce and outcomes 2021 Open
Aims To survey the national workforce that manages children and adolescents with type 1 diabetes (T1D) in Aotearoa New Zealand and compare with glycaemic outcomes for 2021. Methods A representative from each tertiary and regional diabetes …
View article: Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes.
Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes. Open
Objective Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes and technology use. Research Design and Methods Cross-sectional analysis of Hb…
View article: Paediatric Medicine—Queensland
Paediatric Medicine—Queensland Open
Background: Continuous glucose monitoring (CGM) improves glycaemia for people affected by type 1 diabetes (T1D) (1) but is not funded in Aotearoa/New Zealand.Aim: This study explores the impact of non-funded CGM on equity of access and ass…
View article: Editorial: Equity in type 1 diabetes technology and beyond: where are we in 2022?
Editorial: Equity in type 1 diabetes technology and beyond: where are we in 2022? Open
Citation: Burckhardt M-A, Addala A and de Bock M (2024) Editorial: Equity in type 1 diabetes technology and beyond: where are we in 2022? Front. Endocrinol. 15:1400240. doi: 10.3389/fendo.2024.1400240
View article: Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes.
Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes. Open
Objective Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes and technology use. Research Design and Methods Cross-sectional analysis of Hb…
View article: Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes.
Improved glycemic outcomes with diabetes technology use independent of socioeconomic status in youth with type 1 diabetes. Open
Objective Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes and technology use. Research Design and Methods Cross-sectional analysis of Hb…
View article: Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial
Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial Open
Introduction Multiple automated insulin delivery (AID) systems have become commercially available following randomised controlled trials demonstrating benefits in people with type 1 diabetes (T1D). However, their real-world utility may be …
View article: Following in Banting’s footsteps or straying from the path? Observations from contemporary diabetes innovation
Following in Banting’s footsteps or straying from the path? Observations from contemporary diabetes innovation Open
While advancements in the treatment of diabetes continue to rapidly evolve, many of the newer technologies have financial barriers to care, opposing the egalitarian ethos of Banting who sold his patent on insulin for a nominal cost to allo…
View article: Analysis of “Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes”
Analysis of “Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes” Open
In an article in Journal of Diabetes Science and Technology, Nanayakkara and colleagues assessed the glycemic efficacy and safety of AndroidAPS, an open-source automated delivery (AID) system, in a crossover randomized controlled trial. Al…